Back to results
US 2016/0375107 A1Published application
Fragile histidine triad (fhit) compositions and uses thereof
AssigneeThe Ohio State University
InventorsCarlo M. Croce, Francesco Trapasso
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for the diagnosis, prognosis and treatment of a cancer associated disorders using the Fhit gene.
Claims13
A pharmaceutical composition for treating a cancer associated disorder, comprising at least one isolated Fhit gene product, and a pharmaceutically-acceptable carrier.
The pharmaceutical composition of claim 13, wherein the cisplatin is present in an amount between about 0.05 mM to about 0.2 mM.
Dependencies are inferred from the claim text.